<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/215C8CB9-38B2-495F-89F4-21D4414B80C6"><gtr:id>215C8CB9-38B2-495F-89F4-21D4414B80C6</gtr:id><gtr:name>University of California, Berkeley</gtr:name><gtr:address><gtr:line1>University of California, Berkeley</gtr:line1><gtr:line2>191 University Hall</gtr:line2><gtr:postCode>CA 94720</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C80FA399-9F25-4473-8481-C60F0F3D5D18"><gtr:id>C80FA399-9F25-4473-8481-C60F0F3D5D18</gtr:id><gtr:name>Cancer Research UK Cambridge Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/7369E051-ECFC-4808-A044-651879C318D1"><gtr:id>7369E051-ECFC-4808-A044-651879C318D1</gtr:id><gtr:name>MRC Cancer Cell Unit</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB2 2XZ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7369E051-ECFC-4808-A044-651879C318D1"><gtr:id>7369E051-ECFC-4808-A044-651879C318D1</gtr:id><gtr:name>MRC Cancer Cell Unit</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB2 2XZ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/215C8CB9-38B2-495F-89F4-21D4414B80C6"><gtr:id>215C8CB9-38B2-495F-89F4-21D4414B80C6</gtr:id><gtr:name>University of California, Berkeley</gtr:name><gtr:address><gtr:line1>University of California, Berkeley</gtr:line1><gtr:line2>191 University Hall</gtr:line2><gtr:postCode>CA 94720</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C80FA399-9F25-4473-8481-C60F0F3D5D18"><gtr:id>C80FA399-9F25-4473-8481-C60F0F3D5D18</gtr:id><gtr:name>Cancer Research UK Cambridge Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/001A9792-C636-4B75-A8D4-A3C1B55359DC"><gtr:id>001A9792-C636-4B75-A8D4-A3C1B55359DC</gtr:id><gtr:firstName>Ashok</gtr:firstName><gtr:surname>Venkitaraman</gtr:surname><gtr:orcidId>0000-0002-6876-2672</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U105359877"><gtr:id>8E2F11F7-28FA-48A8-A146-A046438FBB11</gtr:id><gtr:title>Chromosomal instability in cancer pathogenesis and treatment</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U105359877</gtr:grantReference><gtr:abstractText>Normal cells tightly control the duplication and integrity of their genetic information encoded in chromosomes, and its segregation into daughter cells during cell division (mitosis). They use complex pathways for DNA repair and mitosis to achieve this. There is mounting evidence that these pathways are disrupted early in the evolution of cancer, leading to instability of chromosome structure and number that promotes the progression of the disease. We are studying human genetic diseases where chromosome instability is associated with cancer to understand the pathways that control DNA repair and mitosis, and how they are altered in cancer cells. Because the majority of drugs currently used to treat cancer affect these pathways, we are studying how alterations in them can affect the response of cancer cells to treatment.|Most new drugs that affect DNA repair or mitosis target an important group of proteins called enzymes, by blocking a particular region (the active site) in them. However, human cells require multiple enzymes to function normally, and the active sites of many of these are similar in structure. Therefore, drugs that block the active sites of enzymes are not sufficiently selective, leading to poor activity, and unwanted side effects in patients. We are developing new ways of making drugs, not by targeting the active sites of enzymes, but by disrupting interactions between proteins, which are necessary for cells to work correctly. We will not only devise methods to find the best targets to disrupt, but will also pioneer new methods to find drugs that disrupt these interactions, and find new ways to test the effect on human cells of the drugs we discover in this way, to evaluate their potential for further development. This work has the potential to transform the basic scientific research that helps us to understand human diseases, as well as the way new drugs are discovered and developed.</gtr:abstractText><gtr:technicalSummary>Epithelial cancer cells exhibit instability in the structure and number of their chromosomes, which is acquired during early steps in carcinogenesis. We study what provokes chromosomal instability, and how it fosters cancer pathogenesis, in order to devise new approaches to cancer therapy that can be applied in clinical practice. We have used interdisciplinary approaches combining genetics and biophysical microscopy to define new pathways underlying chromosomal instability, and engineered novel murine models to explore their role in epithelial carcinogenesis. We have established unique platforms for functional genomics to scan these pathways for the most-promising therapeutic targets, and new strategies to discover chemical leads against them. Through a network of established collaborations, we use preclinical models and early-phase clinical trials to exploit chromosomal instability mechanisms in therapy. Thus our research bridges the laboratory and the clinic to improve the outcome of patients suffering from common forms of epithelial cancer.|</gtr:technicalSummary><gtr:fund><gtr:end>2013-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2001-08-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>6432606</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Chris Abell, David Spring</gtr:description><gtr:id>65AA5562-3339-48B1-B401-5BC23FA6F3DD</gtr:id><gtr:impact>Outputs: Grant income &amp;gt;&amp;pound;7M, several joint coauthored publications.

Multidisciplinary: Our MRC-funded team- protein biochemistry, structural biology, molecular cell biology, biophysics, assay development, computational modeling and structural chemistry, molecular imaging. Partners- organic synthetic chemistry</gtr:impact><gtr:outcomeId>NiLEDsEVQX8-1</gtr:outcomeId><gtr:partnerContribution>Our partners bring skills in organic synthetic chemistry.</gtr:partnerContribution><gtr:piContribution>This forms part of a multi-disciplinary collaboration to pioneer new approaches for the discovery and development of chemical tools that modulate new structural classes of molecular targets for chemical biology and therapeutics development. The MRC-funded research team in my laboratory contributes to work in protein biochemistry, structural biology, molecular cell biology, biophysics, assay development, computational modeling and structural chemistry, and molecular imaging.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biochemistry</gtr:department><gtr:description>Luca Pellegrini</gtr:description><gtr:id>22CC0D35-8C2B-4817-95FC-06592E23F69C</gtr:id><gtr:impact>PubMed ID- 16914443</gtr:impact><gtr:outcomeId>AD2D315A9CE-1</gtr:outcomeId><gtr:partnerContribution>Exchange of research methods and knowledge</gtr:partnerContribution><gtr:piContribution>Exchange of research methods and knowledge</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, Berkeley</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Molecular &amp; Cell Biology</gtr:department><gtr:description>Stephen C. Kowalczykowski</gtr:description><gtr:id>F88DD977-B6CD-4905-9672-824258CE4E4A</gtr:id><gtr:impact>PubMed ID- 19303847</gtr:impact><gtr:outcomeId>25CCF272645-1</gtr:outcomeId><gtr:partnerContribution>Exchange of knowledge and research methods</gtr:partnerContribution><gtr:piContribution>Exchange of knowledge and research methods</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biochemistry</gtr:department><gtr:description>Tom Blundell</gtr:description><gtr:id>CFB2A137-266D-4B8E-9A76-750477FB8CE4</gtr:id><gtr:impact>PubMed ID- 19141287</gtr:impact><gtr:outcomeId>123A0B7BB78-1</gtr:outcomeId><gtr:partnerContribution>Exchange of knowledge and research methods</gtr:partnerContribution><gtr:piContribution>Exchange of knowledge and research methods</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>David Klenerman</gtr:description><gtr:id>53DFFF72-1616-43B8-8C91-77EE083ABD3E</gtr:id><gtr:impact>PubMed ID- 19628690</gtr:impact><gtr:outcomeId>6E5BFCC059E-1</gtr:outcomeId><gtr:partnerContribution>Exchange of research methods and knowledge</gtr:partnerContribution><gtr:piContribution>Exchange of research methods and knowledge</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK Cambridge Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dave Tuveson</gtr:description><gtr:id>9E0763D5-9C6B-4389-9CD7-42D90E08EEDC</gtr:id><gtr:impact>Yes</gtr:impact><gtr:outcomeId>B88EEYXJJrW-1</gtr:outcomeId><gtr:partnerContribution>Exchange of research tools and knowledge</gtr:partnerContribution><gtr:piContribution>Exchange of research methods and knowledge</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Gurdon Institute</gtr:department><gtr:description>Jon Pines</gtr:description><gtr:id>D2D42A55-30F6-4CE2-8788-F2C2245E403E</gtr:id><gtr:impact>PubMed ID- 19820702</gtr:impact><gtr:outcomeId>1691BE5B1BE-1</gtr:outcomeId><gtr:partnerContribution>Exchange of knowledge and research tools</gtr:partnerContribution><gtr:piContribution>Exchange of knowledge and research tools</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>MRC Press Release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BA80ED9C-2DD4-438F-88AE-BBC1D5EC44F4</gtr:id><gtr:impact>Press release on 'New insights to cancer drug resistance found' http://www.mrc.ac.uk/Newspublications/News/MRC006393

Increased knowledge and awareness of research.</gtr:impact><gtr:outcomeId>A1E729C72BB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.mrc.ac.uk/Newspublications/News/MRC006393</gtr:url><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview on Ecancer.tv</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1B669FA6-14A6-41EC-B882-9197BDA9200D</gtr:id><gtr:impact>Interview on Ecancer.tv web channel- The mitotic spindle and potential development for targeting novel types of interactions

Increased knowledge and awareness of research.</gtr:impact><gtr:outcomeId>3ACC1FED005</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Featured in MRC Network</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FEB4C332-CD1A-4230-A01E-832CD16E1E1F</gtr:id><gtr:impact>Research on BRCA2/pancreatic cancer appeared in research round-up section of MRC Network- http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC007661

Increased research profile.</gtr:impact><gtr:outcomeId>iuaGBvvZJv4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC007661</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Feature on Cambridge University news site (2)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2766BE46-44D7-4C76-BDCA-A98FCC2C745C</gtr:id><gtr:impact>News feature on international cancer research collaboration with high-profile institutions in India supported by c.&amp;pound;11million from the Indian Government. http://news.admin.cam.ac.uk/news/2012/10/05/breakthrough-medical-research-collaboration-receives-indian-government-funding-boost/

Increased profile for unit and awareness of research.</gtr:impact><gtr:outcomeId>NKHMRw2qjRn</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Press Release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1E881122-6329-411F-A430-B1E77395AA25</gtr:id><gtr:impact>Press release on 'Unravelling the workings of BRCA2' http://www.mrc.ac.uk/Newspublications/News/MRC006223

Increased knowledge and awareness of research.</gtr:impact><gtr:outcomeId>918FFBE161C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.mrc.ac.uk/Newspublications/News/MRC006223</gtr:url><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CAM magazine interview</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8861DE8C-1135-4A6D-B64A-0F93043DBCF9</gtr:id><gtr:impact>Interviewed for Cambridge University alumni magazine, CAM.

Increased awareness of research in alumni community.</gtr:impact><gtr:outcomeId>C282D156B21</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview on BBC Radio Cambridgeshire</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2AC26986-A9C7-4AF6-BA59-450931148BDC</gtr:id><gtr:impact>Interview on local radion Drivetime programme to discuss cancer research and promote cambridge science festival activities

Increased awareness of research and attendance at festival event</gtr:impact><gtr:outcomeId>543e4c4c6a6237.42995797</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC webstory</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>05E10BB3-E535-46AF-A322-948571EBE573</gtr:id><gtr:impact>Pancreatic cancer and BRCA2 http://www.mrc.ac.uk/Newspublications/News/MRC007553

Increased knowledge and awareness of research.</gtr:impact><gtr:outcomeId>gECq2QoMZu3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.mrc.ac.uk/Newspublications/News/MRC007553</gtr:url><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>41C05B30-BA26-41BC-9D9F-1965A3BC0D3C</gtr:id><gtr:impact>Around 2000 visitors passed through the Biology Zone where the CCU stand was located. We spoke to many adults about cancer research as children took part in hands on activities.

Increased awareness of cancer research and the work of the unit.</gtr:impact><gtr:outcomeId>bkwFdkv9VXb</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival 2013</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C6378FD4-9C8A-4848-A662-571E08617910</gtr:id><gtr:impact>Around 4,000 people passed through the Biology Zone, with many taking part in our activities, reading posters, etc.

Increased profile for unit, and engagement with a younger audience.</gtr:impact><gtr:outcomeId>CBNmRcqwbKf</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5C8E9B9B-F2D2-4618-9730-D8CF0C0FA43D</gtr:id><gtr:impact>Members of the group coordinated activities and spoke to the public about their work.

Increased knowledge about science.</gtr:impact><gtr:outcomeId>B9FC0561460</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Feature on Cambridge University news site</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2C55CCE7-BAEE-4B99-8B7B-9A0A919BD3E3</gtr:id><gtr:impact>Appeared in Cambridge University news feature on appointment as Jubilee Professor by Indian Academy of Sciences. http://news.admin.cam.ac.uk/news/2012/06/27/cambridge-scientist-appointed-inaugural-jubilee-professor-of-the-indian-academy-of-sciences/

Increased profile for unit and awareness of research.</gtr:impact><gtr:outcomeId>mutHdjbCFEn</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Centenary Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4663F351-52F5-4E5F-A7CD-F1938442A7CC</gtr:id><gtr:impact>Around 100 pupils and teachers visited the unit, took part in hands-on activities and heard from our cancer researchers about their careers.

Increased engagement with local schools.</gtr:impact><gtr:outcomeId>ANG5xwBfPU4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Feature in Cambridge News</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>AF968DC6-0ECE-405E-85A1-DF275B5F80EC</gtr:id><gtr:impact>Appeared in a feature on the Unit in the Cambridge News, the city's local newspaper which has regional reach across the county. Feature included in both print and online versions, increasing audience. http://www.cambridge-news.co.uk/Health/Health-and-wellbeing/A-decade-of-discovery-in-cancer-fight-at-Addenbrookes-30042012.htm

Increased awareness of cancer research and the work of the unit.</gtr:impact><gtr:outcomeId>sdfkUMbguzt</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cambridge-news.co.uk/Health/Health-and-wellbeing/A-decade-of-discovery-in-cancer-fight-at-Addenbrookes-30042012.htm</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article in Cambridge News</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>48D0D539-5368-433D-9126-857459B70721</gtr:id><gtr:impact>News article in regional newspaper (print and online) on recent research publication.

Increase in unit profile.</gtr:impact><gtr:outcomeId>mLE4uGDbo2z</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cambridge-news.co.uk/Health/Health-news/Cancer-researchers-in-Cambridge-discover-how-cells-repair-their-DNA-to-avoid-cancer-20131007060913.htm</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Institution Schools event</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7DFD9326-F597-4086-90CE-A90FD8E6F261</gtr:id><gtr:impact>Gave lecture to schools audience at Disneyland, Paris.

Increased understanding of science.</gtr:impact><gtr:outcomeId>C0EDAC8D9DD</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Strategic Award</gtr:description><gtr:end>2016-05-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>FF29AAA1-91FC-4326-A54F-8288A09A8759</gtr:id><gtr:outcomeId>f4u2Xo7eBiN0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>464000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EU FP7 Award</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>4550D13E-6D22-4C78-A7A0-D4B2C45581AE</gtr:id><gtr:outcomeId>dwbUviMWZAa0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>115000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CCC PhD Studentship - Campbell</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Cambridge Cancer Centre</gtr:fundingOrg><gtr:id>3D8C6EF1-1BC6-402A-9D65-CEC53F718EA4</gtr:id><gtr:outcomeId>JTvc8kNh2Yr</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>897000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>35040327-EAD1-478E-8A46-B8B1A9413482</gtr:id><gtr:outcomeId>W5yXaWSwxfq</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>352371</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Aurora-A SDDI</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>DE2668C5-80FB-4EF7-9109-6FEB5595980E</gtr:id><gtr:outcomeId>oSRscWjrJAb</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Academy of Medical Sciences</gtr:description><gtr:end>2015-05-02</gtr:end><gtr:fundingOrg>Academy of Medical Sciences (AMS)</gtr:fundingOrg><gtr:id>8032362A-025E-44DB-A52E-3646EC23D02C</gtr:id><gtr:outcomeId>BBTnvpe8cxF</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Research Fellowship (Studentship) - S Ahmad</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Cambridge Cancer Centre</gtr:fundingOrg><gtr:id>5BD8D6A1-6724-4739-8DCA-2C474BD00861</gtr:id><gtr:outcomeId>skcNhBX8Z8g</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>164396</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (Connecting defective replication initiation to inherited human diseases: Biochemical and genetic analysis of the RecQL4 helicase)</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>128ABEBD-B508-489E-81EB-1EDC8849EB80</gtr:id><gtr:outcomeId>FF484B2E4050</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>252944</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC- Fellowship</gtr:description><gtr:end>2012-11-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>3B3FFC0F-038C-4E66-B257-1FF5AFB7CFD3</gtr:id><gtr:outcomeId>U6bcJhaSxu70</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GATES Scholarship- Fries</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>10278292</gtr:fundingRef><gtr:id>5FDF0763-708B-4496-973E-931DC089E093</gtr:id><gtr:outcomeId>tyB9GTPa1B3</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>294540</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust SDDI</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>784941EB-D09C-40DA-B4C0-07FCFA5E88AB</gtr:id><gtr:outcomeId>GoYKiFmL1je</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>AURORA A overexpression as a marker for Taxol-resistance in cancer therapy.</gtr:description><gtr:id>267CDA65-C89C-4FD3-8A4C-D7C003A9C3CB</gtr:id><gtr:impact>Facilitated further improvements in healthcare.</gtr:impact><gtr:outcomeId>F9A460CD1D6</gtr:outcomeId><gtr:stage>Refinement.  Clinical</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>Marker for Taxol-resistance in cancer therapy</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2006</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>New computational method for the analysis of biomolecular structures to identify features of the interactions between protein kinases and their inhibitors.</gtr:description><gtr:id>8E4AC5DB-7C56-4F92-9DBB-6E9C5C7935D8</gtr:id><gtr:impact>Cited by other researchers.</gtr:impact><gtr:outcomeId>B4973699888</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Kinase/inhibitor analysis</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Production of thermosensitive degron for conditional genetics in an avian cell line</gtr:description><gtr:id>83B35D3E-947E-429C-9D9E-4D9DF6DA6DD0</gtr:id><gtr:impact>Cited by other researchers. Facilitated further research.</gtr:impact><gtr:outcomeId>17209D8F686</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Thermosensitive degron</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>CA7F39E1-DCA0-43F0-A834-8E6D727DC76A</gtr:id><gtr:title>Beyond cancer genomics: after the end of the beginning.</gtr:title><gtr:parentPublicationTitle>Current opinion in genetics &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eaeb2e81353ecad12ce5da26aad67c13"><gtr:id>eaeb2e81353ecad12ce5da26aad67c13</gtr:id><gtr:otherNames>Venkitaraman AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0959-437X</gtr:issn><gtr:outcomeId>pm_13318_28_22402446</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEC06517-2E24-4003-934C-FDB65D2C5F94</gtr:id><gtr:title>c-ABL tyrosine kinase stabilizes RAD51 chromatin association.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/070becb150111adb0eb54d97e688c56d"><gtr:id>070becb150111adb0eb54d97e688c56d</gtr:id><gtr:otherNames>Shimizu H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>FFD84C5D9ED</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB52028D-D0AD-4D1D-9A0E-535148AE7298</gtr:id><gtr:title>A white light confocal microscope for spectrally resolved multidimensional imaging.</gtr:title><gtr:parentPublicationTitle>Journal of microscopy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82390161a5c56ca532b848752a177ca5"><gtr:id>82390161a5c56ca532b848752a177ca5</gtr:id><gtr:otherNames>Frank JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-2720</gtr:issn><gtr:outcomeId>8E4E0F05B36</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0649201B-DB04-4579-81B2-9B0E9A456EAC</gtr:id><gtr:title>The BRC repeats of human BRCA2 differentially regulate RAD51 binding on single- versus double-stranded DNA to stimulate strand exchange.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56e98017e7a9c309d3e89ffe766848a0"><gtr:id>56e98017e7a9c309d3e89ffe766848a0</gtr:id><gtr:otherNames>Shivji MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>C8007C4C7DB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EE17D50-D1D5-4DB2-A42C-AFFE0A67C0F6</gtr:id><gtr:title>A mitotic function for the high-mobility group protein HMG20b regulated by its interaction with the BRC repeats of the BRCA2 tumor suppressor.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52329ae785e789fb6117f1ddca3cd12b"><gtr:id>52329ae785e789fb6117f1ddca3cd12b</gtr:id><gtr:otherNames>Lee M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>LPxtDBfpjWg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D1517A0-EBDC-4F9A-9E47-00F5AA8C499A</gtr:id><gtr:title>A-type lamins maintain the positional stability of DNA damage repair foci in mammalian nuclei.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1700422215cd472efef9d11f67e1c5b"><gtr:id>d1700422215cd472efef9d11f67e1c5b</gtr:id><gtr:otherNames>Mahen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13318_28_23658700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5600F414-54A3-426C-87C6-9DC80F9943CA</gtr:id><gtr:title>Cancer suppression by the chromosome custodians, BRCA1 and BRCA2.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eaeb2e81353ecad12ce5da26aad67c13"><gtr:id>eaeb2e81353ecad12ce5da26aad67c13</gtr:id><gtr:otherNames>Venkitaraman AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>5436a0736524f5.66150703</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DF62B82-9B28-499A-8AC8-DD17777DD77D</gtr:id><gtr:title>A vertebrate N-end rule degron reveals that Orc6 is required in mitosis for daughter cell abscission.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2369a5eddc953198a72ac8ce5a53175d"><gtr:id>2369a5eddc953198a72ac8ce5a53175d</gtr:id><gtr:otherNames>Bernal JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>Cw6EpaPB4Nf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFF5E2F6-7B9A-4D9B-BE61-174E8D82A327</gtr:id><gtr:title>Two modules in the BRC repeats of BRCA2 mediate structural and functional interactions with the RAD51 recombinase.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3008bc17979baa217fe4ab91c7cbfb63"><gtr:id>3008bc17979baa217fe4ab91c7cbfb63</gtr:id><gtr:otherNames>Rajendra E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>54830F63DBD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F91BA090-6FF4-44D4-9D04-557F1A475717</gtr:id><gtr:title>Recruitment of phosphorylated NPM1 to sites of DNA damage through RNF8-dependent ubiquitin conjugates.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/369b48e663a27f23ce458c966d57f411"><gtr:id>369b48e663a27f23ce458c966d57f411</gtr:id><gtr:otherNames>Koike A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>my8crnEBS1t</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70565A20-9786-44CA-94D6-84B567A0E54E</gtr:id><gtr:title>Does metabolite deficiency mark oncogenic cell cycles?</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eaeb2e81353ecad12ce5da26aad67c13"><gtr:id>eaeb2e81353ecad12ce5da26aad67c13</gtr:id><gtr:otherNames>Venkitaraman AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>HRtDeUz6tyQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>247A1CF4-9D27-47E3-8117-A215C631F61C</gtr:id><gtr:title>From crystal packing to molecular recognition: prediction and discovery of a binding site on the surface of polo-like kinase 1.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df3b72a3a23e9ddd32f2e074bedfe7d1"><gtr:id>df3b72a3a23e9ddd32f2e074bedfe7d1</gtr:id><gtr:otherNames>Sledz P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>EAGz9bzLq6G</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A32AD7BF-9086-4D23-9C83-F5F289F6140E</gtr:id><gtr:title>Diversity-oriented synthesis as a tool for identifying new modulators of mitosis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5966b8b69ea8c08c65551eb5584b90da"><gtr:id>5966b8b69ea8c08c65551eb5584b90da</gtr:id><gtr:otherNames>Ibbeson BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5436a0745dc985.18189042</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B784D88-4C10-4F23-9E9B-EDE18D8D14F8</gtr:id><gtr:title>Rational methods for the selection of diverse screening compounds.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ef757e50484b76f4957c1c3dad0edcc"><gtr:id>1ef757e50484b76f4957c1c3dad0edcc</gtr:id><gtr:otherNames>Huggins DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn><gtr:outcomeId>FHcEY1CiBw7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F1E3085-9613-4117-9210-3D3BA8A05B27</gtr:id><gtr:title>p53 shapes genome-wide and cell type-specific changes in microRNA expression during the human DNA damage response.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7de3df12752ce5f2ad67ba8b804a0bc"><gtr:id>f7de3df12752ce5f2ad67ba8b804a0bc</gtr:id><gtr:otherNames>Hattori H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>545e5a97e8b238.79182008</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03B2820E-28BA-4FC1-931A-F5A6DF0D47EE</gtr:id><gtr:title>DNA damage regulates the mobility of Brca2 within the nucleoplasm of living cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0f8965e8e8465c924c0a035380d968b"><gtr:id>e0f8965e8e8465c924c0a035380d968b</gtr:id><gtr:otherNames>Jeyasekharan AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>rcVHjoM6YqD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69257FB8-6E27-4A7D-BDE0-1D40315C33CB</gtr:id><gtr:title>Kruppel-associated Box (KRAB)-associated co-repressor (KAP-1) Ser-473 phosphorylation regulates heterochromatin protein 1? (HP1-?) mobilization and DNA repair in heterochromatin.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e414d79967042b7e9a6026b44adde3ec"><gtr:id>e414d79967042b7e9a6026b44adde3ec</gtr:id><gtr:otherNames>Bolderson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_13318_28_22715096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67D646FC-1929-42BB-B3AF-595695D69146</gtr:id><gtr:title>A region of human BRCA2 containing multiple BRC repeats promotes RAD51-mediated strand exchange.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56e98017e7a9c309d3e89ffe766848a0"><gtr:id>56e98017e7a9c309d3e89ffe766848a0</gtr:id><gtr:otherNames>Shivji MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>F11F2C2ED67</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D512E39-ED71-4239-9A8C-2C1E9C017444</gtr:id><gtr:title>Design and application of a confocal microscope for spectrally resolved anisotropy imaging.</gtr:title><gtr:parentPublicationTitle>Optics express</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f542cf3e85d9fc356dcf95ba1bac77f"><gtr:id>4f542cf3e85d9fc356dcf95ba1bac77f</gtr:id><gtr:otherNames>Esposito A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1094-4087</gtr:issn><gtr:outcomeId>CitX7nbHF64</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFAB70AE-6486-48D6-87ED-21EE6677E956</gtr:id><gtr:title>An increase in DNA double-strand breaks, induced by Ku70 depletion, is associated with human papillomavirus 16 episome loss and de novo viral integration events.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/285971162ae020cd94a848c1b5607434"><gtr:id>285971162ae020cd94a848c1b5607434</gtr:id><gtr:otherNames>Winder DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>992298ACEDE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FCE1C4E-7845-437F-AD51-07E2F9891411</gtr:id><gtr:title>The breast cancer susceptibility gene BRCA2 is required for the maintenance of telomere homeostasis.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04cf5b89a314c3672f71a41a524be3a3"><gtr:id>04cf5b89a314c3672f71a41a524be3a3</gtr:id><gtr:otherNames>Min J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_13318_28_22187435</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0681DB79-03C6-4E2C-8631-94763ACE4736</gtr:id><gtr:title>Cell-cycle coordination between DNA replication and recombination revealed by a vertebrate N-end rule degron-Rad51.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ca73d86e76e34916939893df1764c38"><gtr:id>2ca73d86e76e34916939893df1764c38</gtr:id><gtr:otherNames>Su X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>29650A9217D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>585109F7-B7F7-4F37-885D-454C4D8C3FD5</gtr:id><gtr:title>Linear aliphatic dialkynes as alternative linkers for double-click stapling of p53-derived peptides.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8586c6b180b864a824ed1eec5eb01a4"><gtr:id>a8586c6b180b864a824ed1eec5eb01a4</gtr:id><gtr:otherNames>Lau YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>545e5a98179cc7.81091990</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F17CC0B5-F4B4-4F52-BABC-443D56E96F10</gtr:id><gtr:title>Mobilization and recruitment of HP1: a bimodal response to DNA breakage.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8271a4e74294184b2dd035f760b3cea8"><gtr:id>8271a4e74294184b2dd035f760b3cea8</gtr:id><gtr:otherNames>Ayoub N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>51A07AEA9E8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71B721E7-1AE3-4483-9C36-0196D4CBA99E</gtr:id><gtr:title>A cancer-associated BRCA2 mutation reveals masked nuclear export signals controlling localization.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0f8965e8e8465c924c0a035380d968b"><gtr:id>e0f8965e8e8465c924c0a035380d968b</gtr:id><gtr:otherNames>Jeyasekharan AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>pm_13318_28_24013206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E477D2F-2BBD-44CB-9450-7B60E951E60E</gtr:id><gtr:title>A mitotic role for the DNA damage-responsive CHK2 kinase.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10b9a6b6fc938ff29e11abdcb06d4396"><gtr:id>10b9a6b6fc938ff29e11abdcb06d4396</gtr:id><gtr:otherNames>Sato K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>JjmnTKu3sGB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>141E0902-E226-4E5E-8AAC-BE510A740A91</gtr:id><gtr:title>Context dependence of checkpoint kinase 1 as a therapeutic target for pancreatic cancers deficient in the BRCA2 tumor suppressor.</gtr:title><gtr:parentPublicationTitle>Molecular cancer therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7de3df12752ce5f2ad67ba8b804a0bc"><gtr:id>f7de3df12752ce5f2ad67ba8b804a0bc</gtr:id><gtr:otherNames>Hattori H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1535-7163</gtr:issn><gtr:outcomeId>ARXh2tT5qCq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CFD0705B-DA84-4E44-A628-11C4DAB6E4AF</gtr:id><gtr:title>Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b09c7c9862afb72a36cc5a02815c918f"><gtr:id>b09c7c9862afb72a36cc5a02815c918f</gtr:id><gtr:otherNames>Russell P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>pm_13318_28_22056875</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C860DE28-7729-4ECB-9128-1FAEE61826D5</gtr:id><gtr:title>A conserved quadruplex motif located in a transcription activation site of the human c-kit oncogene.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e1f7401b5ae7388db82dd0d90ccabaf"><gtr:id>5e1f7401b5ae7388db82dd0d90ccabaf</gtr:id><gtr:otherNames>Fernando H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>A05084054AC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9A54560-5390-4E22-8CBD-67136C0087EB</gtr:id><gtr:title>Modifying chromatin architecture during the response to DNA breakage.</gtr:title><gtr:parentPublicationTitle>Critical reviews in biochemistry and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eaeb2e81353ecad12ce5da26aad67c13"><gtr:id>eaeb2e81353ecad12ce5da26aad67c13</gtr:id><gtr:otherNames>Venkitaraman AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1040-9238</gtr:issn><gtr:outcomeId>1F0C285CC42</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>004B1DE8-3966-45FC-8584-AE89DF96ABB0</gtr:id><gtr:title>Human inositol polyphosphate multikinase regulates transcript-selective nuclear mRNA export to preserve genome integrity.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a19d29473af70d14c697b8cd9ba75e65"><gtr:id>a19d29473af70d14c697b8cd9ba75e65</gtr:id><gtr:otherNames>Wickramasinghe VO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>pm_13318_28_24074953</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8335068D-12DB-4AA3-9067-43E07540B900</gtr:id><gtr:title>A two-directional strategy for the diversity-oriented synthesis of macrocyclic scaffolds.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b68d52fe947fbc3f051f973559d28a53"><gtr:id>b68d52fe947fbc3f051f973559d28a53</gtr:id><gtr:otherNames>O'Connell KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>pm_13318_28_22890306</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E56895D8-1972-4328-8D9B-9FEDBC40D181</gtr:id><gtr:title>Chromosome instability and carcinogenesis: insights from murine models of human pancreatic cancer associated with BRCA2 inactivation.</gtr:title><gtr:parentPublicationTitle>Molecular oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1333dc61a50bcdc0960fd1f4abc240f"><gtr:id>d1333dc61a50bcdc0960fd1f4abc240f</gtr:id><gtr:otherNames>Cassidy LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1574-7891</gtr:issn><gtr:outcomeId>5436a074935226.20290992</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAF096CC-E53E-41BF-8AE9-787472E992E3</gtr:id><gtr:title>Chromosomal instability in cancer: causality and interdependence.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eaeb2e81353ecad12ce5da26aad67c13"><gtr:id>eaeb2e81353ecad12ce5da26aad67c13</gtr:id><gtr:otherNames>Venkitaraman AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>AB2BB518A89</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9B1287D-9A80-4E97-AC10-81EA8C291767</gtr:id><gtr:title>Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment.</gtr:title><gtr:parentPublicationTitle>Annual review of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eaeb2e81353ecad12ce5da26aad67c13"><gtr:id>eaeb2e81353ecad12ce5da26aad67c13</gtr:id><gtr:otherNames>Venkitaraman AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-4006</gtr:issn><gtr:outcomeId>9155967BF19</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61769583-5600-46DC-B6C5-029ABBCD6610</gtr:id><gtr:title>Novel structural features of CDK inhibition revealed by an ab initio computational method combined with dynamic simulations.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f54a9140128e3e334d243293ae4e6eb5"><gtr:id>f54a9140128e3e334d243293ae4e6eb5</gtr:id><gtr:otherNames>Heady L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>944EF5522E0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D0E0D34-87DE-4E9D-BA7E-EFB8C1DB64D3</gtr:id><gtr:title>The crystal structure of the N-terminal region of BUB1 provides insight into the mechanism of BUB1 recruitment to kinetochores.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/079235d1b2a99a638a8d7930eb46dec9"><gtr:id>079235d1b2a99a638a8d7930eb46dec9</gtr:id><gtr:otherNames>Bolanos-Garcia VM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>3435545507A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F92F1E43-45F2-4220-B0CD-C2615CD382AC</gtr:id><gtr:title>Pattern formation in centrosome assembly.</gtr:title><gtr:parentPublicationTitle>Current opinion in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1700422215cd472efef9d11f67e1c5b"><gtr:id>d1700422215cd472efef9d11f67e1c5b</gtr:id><gtr:otherNames>Mahen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0955-0674</gtr:issn><gtr:outcomeId>pm_13318_28_22245706</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80E517A6-3A28-40AA-918E-3C04AEC118CD</gtr:id><gtr:title>Genome instability mechanisms and the structure of cancer genomes.</gtr:title><gtr:parentPublicationTitle>Current opinion in genetics &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1333dc61a50bcdc0960fd1f4abc240f"><gtr:id>d1333dc61a50bcdc0960fd1f4abc240f</gtr:id><gtr:otherNames>Cassidy LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0959-437X</gtr:issn><gtr:outcomeId>pm_13318_28_22366532</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABD7814A-AD24-4A0A-A8AF-7476E895E4E7</gtr:id><gtr:title>Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancer.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f58808908bfb94661f3ac4cc90666e5"><gtr:id>7f58808908bfb94661f3ac4cc90666e5</gtr:id><gtr:otherNames>Skoulidis F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn><gtr:outcomeId>bPzzisjN5bd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C4431D3-060C-4380-9C1F-BF2018E45E7B</gtr:id><gtr:title>Cancer: Let sleeping DNA lie.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eaeb2e81353ecad12ce5da26aad67c13"><gtr:id>eaeb2e81353ecad12ce5da26aad67c13</gtr:id><gtr:otherNames>Venkitaraman AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>qjgFxeSBB7p</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C168D65-03B3-4309-B74A-0A0F3A65B571</gtr:id><gtr:title>Interrogation of the protein-protein interactions between human BRCA2 BRC repeats and RAD51 reveals atomistic determinants of affinity.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74caa858e1c4622a8245ad51cfc3acbe"><gtr:id>74caa858e1c4622a8245ad51cfc3acbe</gtr:id><gtr:otherNames>Cole DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>XuscLzVoNiw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AF9B541-2845-41AF-A9BC-C9699A278B27</gtr:id><gtr:title>The BRC repeats of BRCA2 modulate the DNA-binding selectivity of RAD51.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98854238a8290dfda25d8315bac5417a"><gtr:id>98854238a8290dfda25d8315bac5417a</gtr:id><gtr:otherNames>Carreira A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>B50ADBA9B35</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2CB88DD-C739-4DF9-8905-5774DCE53311</gtr:id><gtr:title>Synthesis and biological profiling of tellimagrandin I and analogues reveals that the medium ring can significantly modulate biological activity.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a340fbb42265c9ec6bc733e0a04c590"><gtr:id>2a340fbb42265c9ec6bc733e0a04c590</gtr:id><gtr:otherNames>Zheng S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>pm_13318_28_22361895</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C1ED07B-66E5-495B-8591-2C00DBD79307</gtr:id><gtr:title>Selective nuclear export of specific classes of mRNA from mammalian nuclei is promoted by GANP.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a19d29473af70d14c697b8cd9ba75e65"><gtr:id>a19d29473af70d14c697b8cd9ba75e65</gtr:id><gtr:otherNames>Wickramasinghe VO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5436a074086e53.17611449</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DDCECBA2-DA7E-41AC-AE4C-CE14974AD1A7</gtr:id><gtr:title>Palladium-catalysed cross-coupling of vinyldisiloxanes with benzylic and allylic halides and sulfonates.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/989c15fc31ab70370cc1b93bf3576260"><gtr:id>989c15fc31ab70370cc1b93bf3576260</gtr:id><gtr:otherNames>Frye EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>pm_13318_28_22678946</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5202A7D3-AFC2-478B-9C6B-4426AA7A0CEE</gtr:id><gtr:title>HERC2 is an E3 ligase that targets BRCA1 for degradation.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e6762650ea24f04eb0c3da85919e9da"><gtr:id>6e6762650ea24f04eb0c3da85919e9da</gtr:id><gtr:otherNames>Wu W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>rqGJYacktbA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53BE7CB1-0573-4486-9C16-649A09107648</gtr:id><gtr:title>Paving the way for H2AX phosphorylation: chromatin changes in the DNA damage response.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8271a4e74294184b2dd035f760b3cea8"><gtr:id>8271a4e74294184b2dd035f760b3cea8</gtr:id><gtr:otherNames>Ayoub N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>A3FED21CE05</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD190671-E7AD-40B7-81E1-7FF4EE612731</gtr:id><gtr:title>Homeostatic control of polo-like kinase-1 engenders non-genetic heterogeneity in G2 checkpoint fidelity and timing.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24ec375abd205ba8e96b7e4e07a57e2b"><gtr:id>24ec375abd205ba8e96b7e4e07a57e2b</gtr:id><gtr:otherNames>Liang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5436a0730c63b3.24331542</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7F9D7CF-4C7C-4114-A831-3E44200537E2</gtr:id><gtr:title>A DNA-damage selective role for BRCA1 E3 ligase in claspin ubiquitylation, CHK1 activation, and DNA repair.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10b9a6b6fc938ff29e11abdcb06d4396"><gtr:id>10b9a6b6fc938ff29e11abdcb06d4396</gtr:id><gtr:otherNames>Sato K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>pm_13318_28_22863316</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>030B099F-2B5C-4712-B7E5-B718F8467CF3</gtr:id><gtr:title>A cancer-associated mutation inactivates a region of the high-mobility group protein HMG20b essential for cytokinesis.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52329ae785e789fb6117f1ddca3cd12b"><gtr:id>52329ae785e789fb6117f1ddca3cd12b</gtr:id><gtr:otherNames>Lee M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>545e5a97c09e68.33250350</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74C8C1CB-7AA2-4726-9F89-465FD929C8EF</gtr:id><gtr:title>The carboxyl terminus of Brca2 links the disassembly of Rad51 complexes to mitotic entry.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8271a4e74294184b2dd035f760b3cea8"><gtr:id>8271a4e74294184b2dd035f760b3cea8</gtr:id><gtr:otherNames>Ayoub N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>A0A35EE7DF7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57AD0AC8-7DC6-43CD-811A-CA0983C58D1C</gtr:id><gtr:title>Continuous polo-like kinase 1 activity regulates diffusion to maintain centrosome self-organization during mitosis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1700422215cd472efef9d11f67e1c5b"><gtr:id>d1700422215cd472efef9d11f67e1c5b</gtr:id><gtr:otherNames>Mahen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>X1Wh5VXfo3g</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1782A8CE-5337-4CAF-A429-7726F6F45B67</gtr:id><gtr:title>G-quadruplex-binding benzo[a]phenoxazines down-regulate c-KIT expression in human gastric carcinoma cells.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e92b74a0a6b0a902a73841b116ab330"><gtr:id>4e92b74a0a6b0a902a73841b116ab330</gtr:id><gtr:otherNames>McLuckie KI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>LcCJboG7n9M</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3FAE727-7A4D-4DD8-B6E2-A9C0E4192BBB</gtr:id><gtr:title>Computational analysis of phosphopeptide binding to the polo-box domain of the mitotic kinase PLK1 using molecular dynamics simulation.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ef757e50484b76f4957c1c3dad0edcc"><gtr:id>1ef757e50484b76f4957c1c3dad0edcc</gtr:id><gtr:otherNames>Huggins DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>PJn5xMBjMNu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1346B053-E65D-4560-AB45-CEDF5988BEC7</gtr:id><gtr:title>The GDI-like solubilizing factor PDEd sustains the spatial organization and signalling of Ras family proteins.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bac50221dc503170820594fbe6ef3a1b"><gtr:id>bac50221dc503170820594fbe6ef3a1b</gtr:id><gtr:otherNames>Chandra A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>pm_13318_28_22179043</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A869BD1-8418-4CD2-9AD3-5AA390693736</gtr:id><gtr:title>High content screening of diverse compound libraries identifies potent modulators of tubulin dynamics.</gtr:title><gtr:parentPublicationTitle>ACS medicinal chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f5b243c4d6b98f63194d44a82af0669"><gtr:id>0f5b243c4d6b98f63194d44a82af0669</gtr:id><gtr:otherNames>Laraia L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1948-5875</gtr:issn><gtr:outcomeId>54369fff59f1d9.42388833</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66E6F2B7-2922-4880-AA76-E0BF2209D434</gtr:id><gtr:title>UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exit.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f950add39fb085d18f9c7ea45686731"><gtr:id>9f950add39fb085d18f9c7ea45686731</gtr:id><gtr:otherNames>Garnett MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>5484377902F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE31EE40-5361-4F31-907E-E28C2AB63C25</gtr:id><gtr:title>Using a fragment-based approach to target protein-protein interactions.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/584952b12d6156f6729a395528a9a0f6"><gtr:id>584952b12d6156f6729a395528a9a0f6</gtr:id><gtr:otherNames>Scott DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>pm_13318_28_23344974</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33F576B8-B626-45DE-83D8-705F593CCD64</gtr:id><gtr:title>Maximizing the biochemical resolving power of fluorescence microscopy.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f542cf3e85d9fc356dcf95ba1bac77f"><gtr:id>4f542cf3e85d9fc356dcf95ba1bac77f</gtr:id><gtr:otherNames>Esposito A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5436a074bd82f0.77861645</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5891B17-B3B6-49D1-85EB-2C9DE86A1791</gtr:id><gtr:title>Investigating peptide sequence variations for 'double-click' stapled p53 peptides.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8586c6b180b864a824ed1eec5eb01a4"><gtr:id>a8586c6b180b864a824ed1eec5eb01a4</gtr:id><gtr:otherNames>Lau YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>5436a0733da501.21421209</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52CD97F2-E0EF-4AF0-AC1A-2C9535766B98</gtr:id><gtr:title>HP1-beta mobilization promotes chromatin changes that initiate the DNA damage response.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8271a4e74294184b2dd035f760b3cea8"><gtr:id>8271a4e74294184b2dd035f760b3cea8</gtr:id><gtr:otherNames>Ayoub N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>BAF8BB12382</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F88D8727-CD0A-4EFD-B695-4822FFE90194</gtr:id><gtr:title>Targeting the molecular defect in BRCA-deficient tumors for cancer therapy.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eaeb2e81353ecad12ce5da26aad67c13"><gtr:id>eaeb2e81353ecad12ce5da26aad67c13</gtr:id><gtr:otherNames>Venkitaraman AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn><gtr:outcomeId>C12ECB9432D</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U105359877</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>